QuidelOrtho Corporation (QDEL) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for QuidelOrtho Corporation (QDEL:NASDAQ), powered by AI.

Current Price
$14.13
Sector
Healthcare
What is the QuidelOrtho Corporation stock price forecast?

QuidelOrtho Corporation is currently trading at $14.13. View real-time AI analysis on Alpha Lenz.

What is QuidelOrtho Corporation insider trading activity?

View the latest insider trading data for QuidelOrtho Corporation on Alpha Lenz.

What is QuidelOrtho Corporation's P/E ratio?

View QuidelOrtho Corporation's valuation metrics on Alpha Lenz.

QuidelOrtho Corporation

NASDAQ · QDEL
$14.13+0.04(+0.28%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about QuidelOrtho Corporation's future dividend policy...
Alpha Chat Insight

QuidelOrtho Corporation's ROE is -46.1%. Explore profitability and growth together.

Ask for details

Company Overview

QuidelOrtho Corporation is a leading manufacturer and provider of diagnostic testing solutions that serve the healthcare industry on a global scale. The company focuses on developing innovative diagnostic products designed to detect and diagnose a variety of medical conditions with increased accuracy and efficiency. QuidelOrtho's portfolio includes rapid diagnostic tests, traditional laboratory assays, and immunoassays that are used in clinical laboratories, hospitals, and primary care environments. The key feature of QuidelOrtho's offerings lies in its emphasis on providing reliable and timely diagnosis, which helps healthcare professionals in making informed decisions for patient care. Products from QuidelOrtho cover a broad spectrum of medical areas, including infectious diseases, cardiology, women’s health, and gastrointestinal conditions, significantly impacting public health outcomes. In the financial market, QuidelOrtho Corporation plays a crucial role in the healthcare sector, especially during times of heightened health crises. The company's commitment to advancing diagnostic technologies underscores its relevance amidst rising demand for rapid and accurate testing solutions in the medical field globally.

CEOMr. Brian J. Blaser
SectorHealthcare
IndustryMedical Devices
Employees6,600

Company Statistics

FY 2025

Profile

N/AMarket Cap
$2.73BRevenue
0.00Shares Out
6,600Employees

Margins

46.67%Gross
17.89%EBITDA
2.01%Operating
-40.57%Pre-Tax
-41.45%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-5.80%Rev 3Yr
10.44%Rev 5Yr
-61.76%Op Inc 3Yr
-44.75%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-18.56%ROA
-46.15%ROE
-15.17%ROIC

Financial Health

$169.80MCash & Cash Equivalents
$3.68BNet Debt
200.41%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

QuidelOrtho Corporation (ticker: QDEL) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 6,600 employees.

The current price is $14.13 with a P/E ratio of -x and P/B of -x.

ROE is -46.15% and operating margin is 2.01%. Annual revenue is $2.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
QuidelOrtho Corporation (QDEL) Stock Forecast 2026 $14.13 — Price, Financials & Analyst Targets | Alpha Lenz